Chemours (CC) Invested Capital (2014 - 2026)

Chemours has reported Invested Capital for 13 years, with the latest figure at $3.8 billion in Q2 2026.

• On a quarterly basis, Invested Capital fell 12.64% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $3.8 billion, a 12.64% decrease from a year earlier, with the FY2025 full-year figure at $4.4 billion, down 6.25% from the prior year.
• Invested Capital was $3.8 billion for Q2 2026 at Chemours, down from $4.4 billion in the prior quarter.
• The five-year high for Invested Capital was $4.9 billion in Q2 2022, with the low at $3.8 billion in Q2 2026.
• Average Invested Capital over 5 years is $4.6 billion, with a median of $4.7 billion recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Invested Capital advanced 5.61% in 2024, then decreased 12.64% in 2026.
• Over 5 years, Invested Capital stood at $4.7 billion in 2022, then advanced by 0.51% to $4.7 billion in 2023, then fell by 0.95% to $4.7 billion in 2024, then fell by 6.25% to $4.4 billion in 2025, then slipped by 12.96% to $3.8 billion in 2026.
• The last three Invested Capital figures came in at $3.8 billion (Q2 2026), $4.4 billion (Q1 2026), and $4.4 billion (Q4 2025), per Business Quant data.